Background Patent foramen ovale (PFO) closure is the gold standard for treating patients
with cryptogenic stroke and PFO. However, scarce data exist on the long-term outcomes …

No data exist on the optimal duration of antithrombotic therapy (AT) following patent foramen
ovale (PFO) closure. We sought to assess the safety of AT discontinuation following PFO …

Objectives: To carry out long-term follow-up after percutaneous closure of patent foramen
ovale (PFO) in patients with cryptogenic stroke. Design: Prospective cohort study. Setting …

Objectives: The purpose of this study was to compare the efficacy of medical treatment with
percutaneous closure of patent foramen ovale (PFO). Background: Patients with cryptogenic …

Background: Percutaneous patent foramen ovale (PFO) closure seems to reduce the risk of
recurrent thromboembolism. We report the safety and efficacy of percutaneous PFO closure …

Objectives: This study sought to examine the frequency of indications for and the immediate
and long-term clinical outcomes of transcatheter closure of patent foramen ovale (PFO) …

Aims Observational studies favor percutaneous closure of patent foramen ovale (PFO) over
medical therapy to reduce the risk of recurrent stroke, whereas randomized clinical trials …

Objectives: The present study was conducted to determine the safety of the transcatheter
closure of a patent foramen ovale (PFO) in patients with cryptogenic cerebral ischemia and …

Background Several studies have shown an association of cryptogenic stroke and embolism
with patent foramen ovale (PFO), but the question how to prevent further events in such …

Patent foramen ovale (PFO) is a common cardiac abnormality with a prevalence of 25% in
the general population. PFO has been associated with the paradoxical embolism causing …